Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. (Q51499900)

6 April 2018

title

Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. (English)

1 reference

6 April 2018

1 reference

1 reference

Braga-Basaria M

1

1 reference

6 April 2018

Muller DC

2

1 reference

6 April 2018

Carducci MA

3

1 reference

6 April 2018

Dobs AS

4

1 reference

6 April 2018

Basaria S

5

1 reference

6 April 2018

publication date

13 April 2006

1 reference

6 April 2018

International Journal of Impotence Research

published in

1 reference

6 April 2018

volume

18

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

494-498

1 reference

6 April 2018

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Long-term effects of androgen deprivation therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Cause of death in men diagnosed with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Changing patterns in competing causes of death in men with prostate cancer: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

The influence of androgen deprivation therapy on metabolism in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

7 January 2021

Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

7 January 2021

The association of hypotestosteronemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

7 January 2021

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901471

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901471

1 reference

6 April 2018

1 reference

6 April 2018